Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

KRX/003120 stock hub

KRX/003120 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

KRX/003120is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

152.3B

Korea Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

KRX/003120

In the news

Latest news · KRX/003120

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 9.8P50 17.1P75 31.9

Trailing P/E130.6

P25 12P50 23.1P75 39.5

ROE0.3

P25 -17.1P50 0.7P75 8.5

ROIC-1.6

P25 -9P50 1.3P75 6.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All KRX/003120 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

205

Groups with data

Currency

KRW

Showing 205 of 205 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	South Korea
Country code	KR
Enterprise value	KRW -73.5B
Exchange	Korea Stock Exchange
Financial currency	KRW
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	KR7003120003
Last refreshed	2026-05-10
Market cap	KRW 152.3B
Price	KRW 21,850
Price currency	KRW
Sector	Healthcare
Sic	2834
Symbol	krx/003120
Website	https://www.ilsungis.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	0.77%
EV Earnings	-63.07x
EV/FCF	-42.11x
FCF yield	1.15%
P/B ratio	0.39x
P/E ratio	130.61x
P/S ratio	2.37x
PE Ratio10 Y	38.65x
PE Ratio3 Y	57.8x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-9.58%
EBITDA Margin	-4.41%
FCF margin	2.72%
Gross margin	43.25%
Gross Profit	KRW 27.8B
Gross Profit Growth	3.07%
Gross Profit Growth Q	20.47%
Gross Profit Growth3 Y	-0.01%
Gross Profit Growth5 Y	16.22%
Net Income	KRW 1.2B
Net Income Growth	-91.1%
Net Income Growth Q	-25.35%
Net Income Growth Years	0%
Net Income Growth3 Y	-77.71%
Net Income Growth5 Y	-18.39%
Pretax Margin	4.4%
Profit Margin	1.81%
Profitable Years	2
ROA	-0.96
Roa5y	-0.73
ROCE	-1.59
ROE	0.3
Roe5y	4.97
ROIC	-1.62
Roic5y	-2.66

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	3.9%
Cagr15y	5.81%
Cagr1y	44.73%
Cagr20y	5.27%
Cagr3y	-1.52%
Cagr5y	13.81%
Div CAGR10	23.11%
Div CAGR3	-7.17%
Div CAGR5	51.57%
EPS Growth Years	0
OCF Growth10 Y	-4.33%
OCF Growth5 Y	20.04%
Revenue Growth	-6.85x
Revenue Growth Q	-13.14x
Revenue Growth Years	0x
Revenue Growth3 Y	1.63x
Revenue Growth5 Y	9.63x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	KRW 0.16
Assets	KRW 403B
Cash	KRW 225.9B
Current Assets	KRW 270B
Current Liabilities	KRW 15.5B
Debt	KRW 132.2M
Debt Equity	KRW 0
Debt FCF	KRW 0.08
Equity	KRW 386.3B
Interest Coverage	-174
Liabilities	KRW 16.7B
Long Term Assets	KRW 133B
Long Term Liabilities	KRW 1.2B
Net Cash	KRW 225.8B
Net Cash By Market Cap	KRW 148
Net Cash Growth	1.65%
Net Debt Equity	KRW -0.58
Net Debt FCF	KRW -129
Tangible Book Value	KRW 383.7B
WACC	3.78

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	17.47
Inventory Turnover	1.33
Net Working Capital	KRW 28.6B
Quick ratio	15.71
Working Capital	KRW 254.5B
Working Capital Turnover	KRW 0.25

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend Growth	20%
Dividend Growth Years	1%
Dividend per share	KRW 1,200
Dividend Years	26
Dividend Yield	5.28%
Ex Div Date	2025-12-29
Last Dividend	KRW 1,200
Payout Frequency	Annual
Payout Ratio	584.62%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	46.63%
1Y total return	44.69%
200-day SMA	23,473.4
3Y total return	-4.48%
50-day SMA	23,187
50-day SMA vs 200-day SMA	50under200
5Y total return	90.92%
All Time High	38,000
All Time High Change	-42.5%
All Time High Date	2023-03-03
All Time Low	287.8
All Time Low Change	7,492.58%
All Time Low Date	1998-09-24
ATR	638.9
Beta	-0.09
Beta1y	0.35
Beta2y	0.31
Ch YTD	0.23
High	21,950
High52	31,450
High52 Date	2025-07-11
High52ch	-30.52%
Low	21,500
Low52	15,780
Low52 Date	2025-05-08
Low52ch	38.47%
Ma50ch	-5.77%
Price vs 200-day SMA	-6.92%
RSI	34.01
RSI Monthly	52.21
RSI Weekly	45.19
Sharpe ratio	1x
Sortino ratio	1.86
Total Return	5.28%
Tr YTD	0.23
Tr15y	133.25%
Tr1m	-1.13%
Tr1w	-3.96%
Tr3m	-2.24%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	KRW -6.2B
Operating margin	-9.58

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	2,422,048%
Net Borrowing	-76,041,290
Shares Insiders	54.71%
Shares Institutions	8.05%
Shares Out	6,968,988

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	KRW 1.7B
Average Volume	4,430.45x
CAPEX	KRW -2.1B
Ch10y	-9.34
Ch15y	40.79
Ch1m	-1.13
Ch1w	-3.96
Ch1y	38.29
Ch20y	63.3
Ch3m	-2.24
Ch3y	-19.07
Ch5y	22.62
Ch6m	-3.96
Change	-0.68%
Change From Open	0.46
Close	22,000
Days Gap	-1.14
Depreciation Amortization	3,322,776,000
Dollar Volume	196,431,500
Earnings Date	2026-02-26
EBIT	KRW -6.2B
EBITDA	KRW -2.8B
F Score	4
FCF	KRW 1.7B
FCF EV Yield	-2.38x
FCF Per Share	KRW 251
Financing CF	1,044,596,980
Fiscal Year End	December
Founded	1,954
Income Tax	KRW 1.7B
Investing CF	4,758,290,190
Is Primary Listing	1
Last Earnings Date	2026-02-26
Last Report Date	2025-12-31
Last Split Date	2023-04-12
Last Split Type	Forward
Ma150	23,037.8
Ma150ch	-5.16%
Ma20	22,965
Ma20ch	-4.86%
Net CF	10,041,501,970
Open	21,750
P FCF Ratio	87.2
P OCF Ratio	39.23
Payment Date	2026-04-10
Position In Range	77.78
Ppne	76,070,602,360
Price Date	2026-05-08
Ptbv Ratio	0.4
Relative Volume	2.03x
Revenue	64,291,702,800x
Tax By Revenue	2.58x
Tax Rate	58.77%
Tr20y	179.36%
Tr6m	0.49%
Volume	8,990
Z Score	7.62

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

KRX/003120 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+5.3%

$1200 annual per share

Payout ratio

+584.6%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+51.6%

1 consecutive years of growth

Total shareholder yield

+5.3%

Next ex-dividend date: 2025-12-29

Performance

KRX/003120 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns KRX/003120?

Insider, institutional, and short-interest positioning.

Institutional ownership

+8.0%

Share of float held by funds and institutions

Insider ownership

+54.7%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

KRX/003120 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

34.0

Neutral momentum band

Price vs 200-day MA

-6.9%

50/200-day relationship not available

Beta (5Y)

-0.09

Less volatile than the market

Sharpe ratio

1.00

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About KRX/003120

Hub-level FAQ points readers to the deeper analysis pages.

What is the current krx/003120 stock rating?

krx/003120 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full krx/003120 analysis?

The full report lives at /stocks/krx/003120/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for krx/003120?

The latest report frames krx/003120 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the krx/003120 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.